Vanda Pharmaceuticals (VNDA) Change in Inventory (2012 - 2026)

Vanda Pharmaceuticals has disclosed Change in Inventory across 14 years of filings, most recently posting -$294000.0 for Q1 2026.

• Change in Inventory for Q1 2026 came in at -$294000.0, down 115.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 30.71% YoY), and the FY2025 annual result was $3.5 million, up 11851.72% from the prior year.
• Change in Inventory came in at -$294000.0 for Q1 2026 at Vanda Pharmaceuticals, down from $1.3 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $1.8 million in Q1 2025 to a low of -$294000.0 in Q1 2026.
• The 5-year median for Change in Inventory is $368000.0 (2025), against an average of $497117.6.
• Across the five-year window, Change in Inventory slumped 133.75% in 2023 and surged 6479.31% in 2025, its largest moves.
• Vanda Pharmaceuticals' Change in Inventory stood at $1.1 million in 2022, then tumbled by 62.21% to $427000.0 in 2023, then slumped by 74.94% to $107000.0 in 2024, then surged by 1096.26% to $1.3 million in 2025, then slumped by 122.97% to -$294000.0 in 2026.
• The last three Change in Inventory figures came in at -$294000.0 (Q1 2026), $1.3 million (Q4 2025), and -$32000.0 (Q3 2025), per Business Quant data.